Archive - September 2023
Nirmatrelvir, Molnupiravir Use Lowers Risks for Omicron-Infected
Madrigal Pharmaceuticals Announces NDA Acceptance and Priority Review of the New Drug Application for Resmetirom for the Treatment of NASH with Liver Fibrosis
Family History Influences Penetrance of Hereditary Cancers
Orchard Therapeutics Announces Acceptance of Biologics License Application for OTL-200 in MLD and Receives Priority Review
Heat-Related Deaths Could Break Records This Year in Phoenix, America’s Hottest City
FDA Issues Complete Response Letter for neffy® (epinephrine nasal spray) New Drug Application with Request for Additional Study
UCB Provides Update on U.S. Regulatory Review of Bimekizumab
37 Percent Diagnosed With Type 1 Diabetes After Age 30